<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="so far, the disease is only slowing down under extreme" exact="social distancing" post="measures that are difficult to maintain. SARS-COV-2 is an"/>
 <result pre="a central energy store. The role lipids play in viral" exact="infection" post="involves the fusion of the viral membrane to the"/>
 <result pre="review, we discuss the role of lipid metabolism in viral" exact="infection" post="as well as the possibility of targeting lipid metabolism"/>
 <result pre="effects of specific lipids involved in lipid remodeling upon coronavirus" exact="infection" post="stay largely unexplored. Earlier reports have shown that most"/>
 <result pre="their activity [42]. As previously shown, the impact of viral" exact="infection" post="on various lipid species has been dramatic. Wu et"/>
 <result pre="been dramatic. Wu et al. showed that the effect of" exact="treatment" post="on SARS patients was long-lived and could significantly impact"/>
 <result pre="et al., recruited 25 SARS survivors 12 years after their" exact="infection" post="and compared them to healthy controls [43]. They demonstrated"/>
 <result pre="believed to be caused by the high dose of steroid" exact="treatment" post="using methylprednisolone [43]. In another study, Nguyen et al."/>
 <result pre="pathways implicate multiple lipid modifying enzymes, which were increased upon" exact="infection" post="including lysocardiolipin acyltransferase (LCLAT), phosphoinositide phosphatase (PIP), and D.G."/>
 <result pre="have also looked at changes in the lipidome profile after" exact="infection" post="with viruses such as Enterovirus A71 and coxsackievirus and"/>
 <result pre="acid, docosahexaenoic acid, and eicosapentaenoic acid were consistently upregulated after" exact="infection" post="[45]. These data highlight the increase in lipid metabolism"/>
 <result pre="highlight the increase in lipid metabolism that occurs after viral" exact="infection" post="where the virus highjacks and utilizes the host lipid"/>
 <result pre="can protect against all caused mortality within six months of" exact="diagnosis" post="with pneumonia with an adjusted hazard ratio of 0.67"/>
 <result pre="the frequency of ventilator-associated pneumonia. Moreover, they studied if the" exact="treatment" post="had favorable outcomes in patients with Acute Physiology and"/>
 <result pre="mg/day) and irbesartan (150 mg/day). Statinâ€™s beneficial impact on viral" exact="infection" post="could be due to its lipid lowering effects that"/>
 <result pre="statins can also help in mitigating the impact of viral" exact="infection" post="through their immunomodulatory and anti-inflammatory properties [60]. This is"/>
 <result pre="cardiovascular patients have been shown to have an elevated COVID-19" exact="infection" post="risk [61]. Additionally, statins can also exert beneficial effects"/>
 <result pre="and potentially other lipid-lowering drugs such as PCSK9 inhibitors for" exact="treatment" post="of COVID-19, especially that of the most severely infected"/>
 <result pre="likely be exploited to counteract the associated complications of COVID-19" exact="infection" post="[76]. On this basis, the FDA-approved immunomodulator FTY720 (Fingolimod),"/>
 <result pre="with slow multiple sclerosis progression and good response to fingolimod" exact="treatment" post="[81]. Recently, more specific functionally related compounds have been"/>
 <result pre="[75] would make it more suitable and promising for the" exact="treatment" post="of COVID-19 patients [76]. Nevertheless, other â€œsphingomimeticâ€� and â€œsphingomodulatingâ€�"/>
 <result pre="Direction Lipid metabolism plays an important role in the viral" exact="infection" post="cycle. This role can be harnessed as anti-viral drugs"/>
 <result pre="the COVID-19 pandemicArch. Med. Sci.202010.5114/aoms.2020.94503 56.TleyjehI.M.KashourT.HakimF.A.ZimmermanV.A.ErwinP.J.SuttonA.J.IbrahimT.Statins for the prevention and" exact="treatment" post="of infections: A systematic review and meta-analysisArch. Intern. Med.20091691658166710.1001/archinternmed.2009.28619822822"/>
 <result pre="A systematic review and meta-analysisArch. Intern. Med.20091691658166710.1001/archinternmed.2009.28619822822 57.DouglasI.EvansS.SmeethL.Effect of statin" exact="treatment" post="on short term mortality after pneumonia episode: Cohort studyBMJ2011342d164210.1136/bmj.d164221471172"/>
 <result pre="the S1P receptor signaling pathways as a promising approach for" exact="treatment" post="of autoimmune and inflammatory diseasesPharmacol. Res.202015410417010.1016/j.phrs.2019.02.00930776422 79.LunaG.AlpingP.BurmanJ.FinkK.Fogdell-HahnA.GunnarssonM.HillertJ.Langer-GouldA.LyckeJ.NilssonP.et al.Infection Risks"/>
</results>
